Editorial Comment on: New treatment approaches for prostate cancer based on peptide analogues

Aristotelis Bamias; Meletios A Dimopoulos

doi:10.1016/j.eururo.2007.12.023

Related publications

Letter2017

Practical Polling for Prostate Cancer: AR-V7–based Treatment Selection

Alastair Lamb, Mitchell G. Lawrence, Shahneen Sandhu

Article2019

New combination therapies for castration-resistant prostate cancer

Mitchell G. Lawrence, Laura H. Porter, Daisuke Obinata, Shahneen Sandhu, Luke A. Selth, Stephen Q. Wong, Nicholas Choo, David Pook, Carmel Pezaro, David L. Goode, Ashlee K. Clark, Melissa Papargiris, Roxanne Toivanen, Scott M. Dehm, Scott M CASCADE, Scott M kConfab, Heather Thorne, Wayne D. Tilley, Richard B. Pearson, Ross D. Hannan, Declan G. Murphy, Mark Frydenberg, Luc Furic, Renea A. Taylor, Gail P. Risbridger

Article2019

New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections

De Clercq Erik

Article2010

Horizon scanning for novel therapeutics for the treatment of prostate cancer

Diletta Bianchini, Andrea Zivi, Shahneen Sandhu, Johann S. de Bono

Article2006

Progressive stent technologies: new approaches for the treatment of cardiovascular diseases

Sophia Vaina, Patrick W. Serruys

Expert Opinion on Drug Delivery